10
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Neutropenia Complicating Rh-Hydrops Fetalis: The Effect of Treatment with Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF)

, , , , &
Pages 193-197 | Received 09 May 1997, Accepted 29 Jul 1997, Published online: 05 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Susanna Esposito & Nicola Principi. (2020) Adjunctive therapy to treat neonatal sepsis. Expert Review of Clinical Pharmacology 13:1, pages 65-73.
Read now

Articles from other publishers (6)

Esther Blanco & Donna L. Johnston. (2012) Neutropenia in infants with hemolytic disease of the newborn. Pediatric Blood & Cancer 58:6, pages 950-952.
Crossref
Mirjam E.A. Rath, Vivianne E.H.J. Smits-Wintjens, Frans J. Walther & Enrico Lopriore. (2011) Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Human Development 87:9, pages 583-588.
Crossref
Akhil Maheshwari & Robert D. Christensen. (2004) Neutropenia in the Neonatal Intensive Care Unit . NeoReviews 5:10, pages e431-e443.
Crossref
Baruch Wolach, Ronit Gavrieli & Avishalom Pomeranz. (2000) Effect of Granulocyte and Granulocyte Macrophage Colony Stimulating Factors (G-CSF and GM-CSF) on Neonatal Neutrophil Functions. Pediatric Research 48:3, pages 369-373.
Crossref
Robert D. Christensen, Darlene A. Calhoun & Lisa M. Rimsza. (2000) A PRACTICAL APPROACH TO EVALUATING AND TREATING NEUTROPENIA IN THE NEONATAL INTENSIVE CARE UNIT. Clinics in Perinatology 27:3, pages 577-601.
Crossref
A. Bédu, P. Rohrlich, C. Farnoux, M. Duval, O. Fenneteau, C. Boissinot, D. Pinquier, J. Cartron, E. Vilmer & Y. Aujard. (1999) Neutropénies allo-immunes néonatales. Intérêt du traitement par facteur de croissance granuleux (G-CSF). Deux nouvelles observations. Archives de Pédiatrie 6:12, pages 1297-1301.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.